Timing clarification: Constellation’s Q2 2026 earnings call is scheduled for today, Thursday, August 6, 2026, at 10:00 a.m. ET—not tomorrow. This preview assumes the results have not yet been released. (investors.constellationenergy.com)
| Metric | Q2 2026 consensus | Q2 2025 actual | Implied growth |
|---|---|---|---|
| Adjusted EPS | $2.34 | $1.91 | ~23% |
| Revenue | $7.49 billion | $6.10 billion | ~23% |
| FY2026 adjusted EPS | $11.74 | Company guidance: $11.00–$12.00 | — |
The published quarterly consensus is based on only three estimates, with EPS ranging from $2.29 to $2.39 and revenue estimates unusually dispersed. Revenue is therefore a relatively weak signal for CEG: commodity pass-throughs, hedging presentation, and the addition of Calpine can make the top line volatile and difficult to compare. Adjusted earnings, gross-margin drivers, operations, cash flow and guidance matter more. (stage.zacks.com)
CEG closed August 5 at $265.16, down approximately 11.5% from the day of its Q1 report. At the current 2026 EPS consensus, the shares trade at roughly 22.6 times earnings. That valuation still assumes a credible multiyear growth story, but the pullback has lowered the hurdle somewhat.
Constellation earned $2.74 of adjusted EPS in Q1 and maintained full-year guidance of $11.00–$12.00. Management said the quarter met its internal expectations and indicated that it wanted to see at least one more quarter before expressing greater confidence in the upper half of the range. (investors.constellationenergy.com)
At the $2.34 Q2 consensus:
That makes management’s guidance language more consequential than a small quarterly beat or miss:
Q2 is the first clean comparison in which Calpine contributes for the entire quarter. The acquisition was the principal driver of Q1 adjusted EPS growth, and management’s original 2026 outlook included roughly $2 per share of Calpine accretion.
The most useful disclosures will be:
Constellation has agreed to sell approximately 4.4 GW of PJM generation assets to LS Power for $5 billion, subject to approvals, and still needs to complete an additional ERCOT divestiture. Management previously assumed that the PJM assets would contribute during the first part of 2026 before being sold. Investors should listen for an updated closing date, net proceeds, debt reduction and whether any of those proceeds will support repurchases. (investors.constellationenergy.com)
Potential issue: A clean headline EPS result could mask weakness if it depends on assets about to be sold or unusually favorable trading and portfolio activity. The quality and durability of Calpine’s contribution matter more than the absolute quarterly number.
Constellation’s investment case depends on operating scarce nuclear and natural-gas assets reliably. In Q1, its operated nuclear fleet posted a 92.3% capacity factor, while the broader gas, oil and pumped-storage fleet had a 4.5% equivalent forced-outage factor. Q1 nuclear performance was affected by 99 planned refueling-outage days. (investors.constellationenergy.com)
Key Q2 operating metrics include:
A nuclear capacity factor around the mid-90% range with limited unplanned outages would be reassuring. Conversely, weak nuclear output or a deterioration in gas-fleet availability could pressure both the quarter and management’s confidence in full-year guidance.
Also watch early contributions from:
CEG disclosed that all its eligible PJM plants cleared the 2028/2029 capacity auction, totaling 18,875 MW, at the $325/MW-day price cap. Those revenues begin June 1, 2028, so they are not a Q2 earnings driver, but they reinforce the longer-term value of the fleet.
Investors should avoid treating the capacity result as fully incremental to nuclear earnings. Capacity revenue from nuclear units is included in the gross-receipts calculation for the nuclear production tax credit, potentially reducing PTC value. Fossil capacity revenue has a more direct earnings impact. Constellation’s own modeling explicitly warns against adding nuclear capacity revenue separately to base earnings. (investors.constellationenergy.com)
For the current quarter, the broader benefit is that Q2 2026 contains a much richer PJM capacity-price environment than the prior-year quarter. The exact earnings effect will depend on:
This may be the most important issue for the stock beyond 2026 guidance.
CEG has positioned approximately 5 GW of nuclear uprates, gas generation and storage projects for potential PJM opportunities. It has also highlighted roughly 147 million MWh of annual nuclear production that could eventually be contracted at premiums to the PTC floor. But management said in Q1 that some customers were waiting for more regulatory clarity before signing deals.
PJM has since advanced a reliability-backstop framework combining bilateral contracting with a central procurement. The proposed central process targets the 2028/2029 shortfall, contemplates long-term capacity commitments and is intended to allocate costs more directly to the load growth driving the need. FERC has also approved an expedited, temporary interconnection track for a limited number of large, shovel-ready capacity projects. (pjm.com)
Investors should listen for:
A new contract is not required for a good quarter, but concrete evidence of commercial progress would probably matter more to the valuation than a modest EPS beat. Vague statements that customer interest remains strong—but with no movement in negotiations—would be less compelling after several quarters of regulatory discussion.
The restart of the 835 MW Crane Clean Energy Center remains an important medium-term project. FERC granted the requested waiver related to transferring capacity interconnection rights, improving the path toward capacity treatment, while NRC licensing, environmental and emergency-preparedness work continues. The NRC held a public restart-related meeting on July 28. (elibrary.ferc.gov)
Key questions for management:
Any delay would matter because Crane is both a visible growth project and evidence that CEG can add firm nuclear generation faster than greenfield alternatives.
CEG repurchased approximately $335 million of stock at an average price near $285 shortly after the Calpine closing, leaving roughly $4.7 billion under its $5 billion authorization. The shares are now below that repurchase price. (investors.constellationenergy.com)
Investors should look for:
Given management’s prior description of the Q1 buyback as an intentional signal of value, a lack of additional purchases at lower prices would require explanation.
| Area | Positive | Concerning |
|---|---|---|
| Q2 adjusted EPS | Above ~$2.40 with high-quality drivers | Below ~$2.30 or dependent on unusual items |
| FY2026 outlook | Upper-half confidence or guidance raise | Lower-half bias or reduced guidance |
| Nuclear operations | Mid-90% capacity factor, few unplanned outages | Material unplanned outages |
| Calpine | On-plan accretion and integration | Weak gas/retail margins or higher costs |
| Divestitures | Clear closing timetable and capital plan | Regulatory delays or uncertain proceeds |
| Data centers | Contract milestones or near-term pipeline | Continued regulatory waiting with no progress |
| Crane | 2027 schedule reaffirmed | Cost increase or schedule slippage |
| Capital allocation | Further repurchases and disciplined deleveraging | Little deployment despite lower share price |
This report is less about whether CEG earns $2.30 or $2.40 in Q2 and more about whether management can demonstrate that:
A modest beat plus unchanged guidance may not be enough by itself. The strongest outcome would combine solid operations, upper-half guidance confidence, clean Calpine execution and tangible progress toward another large-load or nuclear contract.